Immuno 2026 Day 2 Highlights: Unraveling the Tumor Microenvironment and New Paths to Overcome Immunotherapy Resistance
100 Influential Women in Oncology in 2026: Key Opinion Leaders in Social Media and Beyond
Rare Cells, Big Stories: What Circulating Tumor Cells Can Tell Us About Cancer
NRG-GU005: SBRT vs Moderately Hypofractionated IMRT in Localized Prostate Cancer
CheckMate 459: Biomarkers of Nivolumab Response in HCC
WCC 2026 Highlights the Human Crisis in Cancer Care Through a Lancet Oncology Commission Discussion
Neha Vapiwala: Addressing Financial Headwinds in Cancer Care with Fumiko Ladd Chino
